Intranasal trimeric sherpabody inhibits SARS-CoV-2 including recent immunoevasive Omicron subvariants.
Mäkelä AR, Uğurlu H, Hannula L, Kant R, Salminen P, Fagerlund R, Mäki S, Haveri A, Strandin T, Kareinen L, Hepojoki J, Kuivanen S, Levanov L, Pasternack A, Naves RA, Ritvos O, Österlund P, Sironen T, Vapalahti O, Kipar A, Huiskonen JT, Rissanen I, Saksela K.
Mäkelä AR, et al. Among authors: ritvos o.
Nat Commun. 2023 Mar 24;14(1):1637. doi: 10.1038/s41467-023-37290-6.
Nat Commun. 2023.
PMID: 36964125
Free PMC article.